NBHRX
Price
$14.79
Change
+$0.06 (+0.41%)
Updated
Jul 3 closing price
Net Assets
967.25M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

NBHRX vs VVIAX

Header iconNBHRX vs VVIAX Comparison
Open Charts NBHRX vs VVIAXBanner chart's image
Neuberger Berman Equity Income R3
Price$14.79
Change+$0.06 (+0.41%)
VolumeN/A
Net Assets967.25M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
NBHRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NBHRX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBHRX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. NBHRX (967M). VVIAX pays higher dividends than NBHRX: VVIAX (2.18) vs NBHRX (1.48). NBHRX was incepted earlier than VVIAX: NBHRX (15 years) vs VVIAX (25 years). NBHRX (1.37) is less costly to investors than VVIAX (0.05). NBHRX is a more actively managed with annual turnover of: 28.00 vs. VVIAX (9.00). NBHRX has a lower initial minimum investment than VVIAX: NBHRX (0) vs VVIAX (3000). NBHRX (12.15) and VVIAX (12.03) have marching annual gain over last year. VVIAX return over 5 years is better than : 80.13 vs. NBHRX (37.65).
NBHRXVVIAXNBHRX / VVIAX
Total Expense Ratio1.370.052,740%
Annual Report Gross Expense Ratio1.370.052,740%
Fund Existence15 years25 years-
Gain YTD12.1136.198195%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets967M189B1%
Annual Yield % from dividends1.482.1868%
Returns for 1 year12.1512.03101%
Returns for 3 years16.2835.1746%
Returns for 5 years37.6580.1347%
Returns for 10 years35.10115.6730%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.